Table 1.

The information of epi-lncRNAs associated with survival in breast cancer subtypes

Subtype	lncRNA name	Alteration of epigenetics	Regulatory elements	Epigenetic alteration	Expression	Multiple Cox HR model(p)	Log-rank test(FDR)
Basal	LINC00393	H3K27ac, H3K4me1	enhancer	up	Up	7.61 × 10–3	3.87 × 10–2
Basal	KB-1836B5.1	H3K27ac, H3K4me1	enhancer	up	Up	1.86 × 10–3	3.87 × 10–2
Basal	CASC11	H3K27ac, H3K4me1, H3K4me3	enhancer	up	Up	7.50 × 10–3	4.15 × 10–2
Basal	RP1-140K8.5	H3K27ac, H3K4me1	enhancer	up	Up	3.74 × 10–2	3.87 × 10–2
Basal	AC005162.1	H3K27ac, H3K4me1	enhancer	up	Up	1.80 × 10–2	3.87 × 10–2
Basal	AC020916.2	H3K27ac, H3K4me1, H3K4me3	enhancer	up	Up	3.96 × 10–3	4.15 × 10–2
Basal	CTC-303L1.2	DNA methylation	enhancer	up	down	2.45 × 10–2	3.14 × 10–2
Basal	RP11-738B7.1	DNA methylation	enhancer	down	Up	6.25 × 10–4	2.45 × 10–2
Basal	SLC26A4-AS1	DNA methylation	promoter	down	Up	0 × 100	7.15 × 10–4
Luminal	LINC01983	DNA methylation	promoter	down	Up	2.53 × 10–2	3.25 × 10–2
Luminal	UCA1	lncRNA regulator	–	–	down	5.14 × 10–3	7.70 × 10–3
Luminal	RP11-221J22.2	lncRNA regulator	–	–	Up	4.81 × 10–2	1.94 × 10–2
Luminal	RP11-221J22.1	lncRNA regulator	–	–	Up	4.66 × 10–2	2.56 × 10–2
Luminal	RP1-212P9.3	lncRNA regulator	–	–	up	2.25 × 10–2	2.56 × 10–2